Brief: Cyclopharm Ltd Says FY21 Revenues Expected In Range Of A$17.5-18.0 Mln
Jan 24 (Reuters) - Cyclopharm Ltd CYC.AX :
* CYCLOPHARM BUSINESS UPDATE-CYC.AX
* FY21 REVENUES EXPECTED IN RANGE OF A$17.5-18.0 MILLION
* EXPECT 2022 TO BE ANOTHER SUCCESSFUL AND PRODUCTIVE YEAR
WITH
FDA PROCESS COMING TO A CONCLUSION IN 2H
Source text for Eikon: ID:nASX7VRfFn
Further company coverage: CYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair